Literature DB >> 10871097

Multicentre study for the development of an in vivo model to evaluate the influence of topical formulations on irritation.

E Schnetz1, T L Diepgen, P Elsner, P J Frosch, A J Klotz, J Kresken, O Kuss, H Merk, H J Schwanitz, W Wigger-Alberti, M Fartasch.   

Abstract

Although skin protective products to prevent irritant skin reactions are in wide use, neither standardized test models to prove differences in efficacy exist, nor has the quality or the reproducibility of results been evaluated in a multicentre approach. This should be mandatory when developing or testing skin care products. Therefore, we have designed a multicentre study in an approach to find a standardized test procedure for the evaluation of skin protective products. In this irritation study, a repeated short-time occlusive irritation test (ROIT) with a standardized protocol has been evaluated in 2 phases (12 days and 5 days protocol) in 4 (n=20) respectively 6 (n=33) skilled centres. The skin reaction was induced by 2 irritants (0.5% aq. SLS and toluene, 2x a day for 30 min). Its modification by 3 different cream bases with different hydrophilicity was analyzed. The irritation was monitored by bioengineering methods (TEWL measurement, colorimetry) and by clinical scoring. The evaluation showed that significant results could already be achieved with the 5-day protocol. Furthermore, in spite of the expected inter-centre variations due to heterogeneity of the individual threshold of irritation, interpretation of clinical score, and inter-instrumental variability, the ranking of the vehicles regarding reduction of the irritant reaction was consistent in all centres.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871097     DOI: 10.1034/j.1600-0536.2000.042006336.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  8 in total

Review 1.  Effectiveness of skin protection creams as a preventive measure in occupational dermatitis: a critical update according to criteria of evidence-based medicine.

Authors:  Birgitta Kütting; Hans Drexler
Journal:  Int Arch Occup Environ Health       Date:  2003-04-08       Impact factor: 3.015

Review 2.  Occupational skin-protection products--a review.

Authors:  J Kresken; A Klotz
Journal:  Int Arch Occup Environ Health       Date:  2003-05-21       Impact factor: 3.015

3.  Occupational skin-care management.

Authors:  Thomas L Diepgen; Howard Maibach
Journal:  Int Arch Occup Environ Health       Date:  2003-06       Impact factor: 3.015

4.  Percutaneous absorption of aromatic amines in rubber industry workers: impact of impaired skin and skin barrier creams.

Authors:  G Korinth; T Weiss; S Penkert; K H Schaller; J Angerer; H Drexler
Journal:  Occup Environ Med       Date:  2006-12-20       Impact factor: 4.402

5.  A Pilot Study to Evaluate the Effects of Topically Applied Cosmetic Creams on Epidermal Responses.

Authors:  Megan N Kelchen; Gopi Menon; Patrick Ten Eyck; Donald Prettypaul; Nicole K Brogden
Journal:  Skin Pharmacol Physiol       Date:  2018-08-15       Impact factor: 3.479

6.  In vitro evaluation of the efficacy of skin barrier creams and protective gloves on percutaneous absorption of industrial solvents.

Authors:  G Korinth; S Geh; K H Schaller; H Drexler
Journal:  Int Arch Occup Environ Health       Date:  2003-05-09       Impact factor: 3.015

7.  Diclofenac delays micropore closure following microneedle treatment in human subjects.

Authors:  Nicole K Brogden; Mikolaj Milewski; Priyanka Ghosh; Lucia Hardi; Leslie J Crofford; Audra L Stinchcomb
Journal:  J Control Release       Date:  2012-08-21       Impact factor: 9.776

8.  Effectiveness of skin protection creams in the prevention of occupational dermatitis: results of a randomized, controlled trial.

Authors:  Robert Winker; Bayda Salameh; Sabine Stolkovich; Michael Nikl; Alfred Barth; Elisabeth Ponocny; Hans Drexler; Gerhard Tappeiner
Journal:  Int Arch Occup Environ Health       Date:  2008-10-30       Impact factor: 3.015

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.